Author Archives: Cara

Ovarian Cancer Therapies in Development

Dr. Coleman, a member of the Alliance’s Scientific and Medical Advisory Board, conducted an interview on ovarian cancer therapies for the Cancer Network. He discussed the heterogeneity of ovarian cancer, … Continue reading 

Posted in News | Leave a comment

Family History of Breast Cancer but no Genetic Mutation Does Not Raise Risk of Ovarian Cancer

Women with a family history of breast cancer but no BRCA1/2 mutation were found to be at average risk for developing ovarian cancer. The prospective study of 8005 women from … Continue reading 

Posted in News | Leave a comment

Trebananib extends PFS in trials

A Phase III trial of a new molecule trebananib (also known as AMG 386) showed that women on the drug were 34 percent less likely to have their ovarian tumors … Continue reading 

Posted in News | Leave a comment

Talcum Powder Raises Ovarian Cancer Risk by Almost One-Quarter

Regular application of talcum powder to a woman’s genital area appears to raise her risk of developing ovarian cancer by 24 percent, according to a new metanalysis. Read an article … Continue reading 

Posted in News | Leave a comment

June 2013 SNMMI Meeting

Society for Nuclear Medicine and Molecular Imaging (SNMMI) Advocate Report from Laurel Pracht As a member of the SNMMI Advocate Advisory Board, formed in 2010 to better bridge the gap … Continue reading 

Posted in News | Leave a comment

New Meta-Analysis of Oral Contraception and Risk of Ovarian Cancer

A new meta-analysis of more than 6000 studies shows that oral contraceptives significantly reduce the risk of ovarian cancer. The risk reduction increases proportionally with duration of use. See the … Continue reading 

Posted in News | Leave a comment

Decreases in Ovarian Cancer Correlate to Decrease in Use of Hormone Replacement Therapy

A new study shows that rates of ovarian cancer decreased around the same time that the use of hormone replacement therapy dropped off. Overall, for women over 50, rates decreased … Continue reading 

Posted in News | Leave a comment

Update on Treatment for Recurrent Ovarian Cancer

A new article summarizes treatment options for women with recurrent ovarian cancer. The article includes information about when to treat a recurrence, what agents are available and the goals of … Continue reading 

Posted in News | Leave a comment

Endometriosis Treatments Lower Ovarian Cancer Risk

Women who had surgery to treat their endometriosis also lowered their risk of developing ovarian cancer. A study of approximately 600 Swedish women found that those who either had one … Continue reading 

Posted in News | Leave a comment

Antidepressant May Help With Chemotherapy Side Effects

A study of 231 cancer patients found that the use of duloxetine (Cymbalta) reduced chemotherapy induce peripheral neuropathy. Patients either recieved Cymbalta or a placebo; in the Cymbalta arm, 59% … Continue reading 

Posted in News | Leave a comment

New Genetic Markers for Ovarian Cancer Discovered

A collaboration of more than 130 institutions analyzing data from more than 200,000 people found two new genetic markers increasing a woman’s risk of developing ovarian cancer. New risk-modifying loci … Continue reading 

Posted in News | Leave a comment

Nightshift Work May Increase Risk of Ovarian Cancer

A study of approximately 3,000 women found an increased risk of developing ovarian cancer for women who worked the nightshift. However, duration of nightshift work did not correspond to increased … Continue reading 

Posted in News | Leave a comment